CN106108233A - 气血循环智能鞋 - Google Patents
气血循环智能鞋 Download PDFInfo
- Publication number
- CN106108233A CN106108233A CN201610517536.XA CN201610517536A CN106108233A CN 106108233 A CN106108233 A CN 106108233A CN 201610517536 A CN201610517536 A CN 201610517536A CN 106108233 A CN106108233 A CN 106108233A
- Authority
- CN
- China
- Prior art keywords
- layer
- sole
- tourmaline
- blood circulation
- intelligent shoe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008280 blood Substances 0.000 title claims abstract description 32
- 229940070527 tourmaline Drugs 0.000 claims abstract description 58
- 229910052613 tourmaline Inorganic materials 0.000 claims abstract description 58
- 239000011032 tourmaline Substances 0.000 claims abstract description 58
- 230000017531 blood circulation Effects 0.000 claims abstract description 37
- 239000004744 fabric Substances 0.000 claims abstract description 11
- 239000002781 deodorant agent Substances 0.000 claims abstract description 10
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims abstract description 9
- 230000036541 health Effects 0.000 claims abstract description 9
- 206010022437 insomnia Diseases 0.000 claims abstract description 9
- 238000002653 magnetic therapy Methods 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims description 33
- 239000003814 drug Substances 0.000 claims description 29
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 26
- 229940079593 drug Drugs 0.000 claims description 22
- 239000002245 particle Substances 0.000 claims description 21
- 230000001954 sterilising effect Effects 0.000 claims description 21
- 230000004087 circulation Effects 0.000 claims description 20
- 238000001179 sorption measurement Methods 0.000 claims description 19
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 18
- 238000004659 sterilization and disinfection Methods 0.000 claims description 18
- 229910052582 BN Inorganic materials 0.000 claims description 14
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical class [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 14
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 claims description 13
- 230000000844 anti-bacterial effect Effects 0.000 claims description 12
- 239000004745 nonwoven fabric Substances 0.000 claims description 12
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 claims description 12
- 229960001082 trimethoprim Drugs 0.000 claims description 12
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 claims description 11
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 claims description 11
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 claims description 11
- 229960003942 amphotericin b Drugs 0.000 claims description 11
- 210000004369 blood Anatomy 0.000 claims description 11
- 229960003913 econazole Drugs 0.000 claims description 11
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 claims description 10
- 239000002674 ointment Substances 0.000 claims description 10
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 9
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 claims description 9
- 238000009530 blood pressure measurement Methods 0.000 claims description 9
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 claims description 9
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 9
- 238000007493 shaping process Methods 0.000 claims description 8
- 238000010521 absorption reaction Methods 0.000 claims description 6
- 239000010985 leather Substances 0.000 claims description 6
- 210000004185 liver Anatomy 0.000 claims description 6
- 239000003463 adsorbent Substances 0.000 claims description 3
- 210000001815 ascending colon Anatomy 0.000 claims description 3
- 230000011514 reflex Effects 0.000 claims description 3
- 210000000813 small intestine Anatomy 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 16
- 230000001737 promoting effect Effects 0.000 abstract description 15
- 230000036772 blood pressure Effects 0.000 abstract description 7
- 230000004089 microcirculation Effects 0.000 abstract description 4
- 230000036737 immune function Effects 0.000 abstract 1
- 238000004513 sizing Methods 0.000 abstract 1
- 230000036039 immunity Effects 0.000 description 11
- 210000002683 foot Anatomy 0.000 description 10
- 230000004060 metabolic process Effects 0.000 description 8
- 230000002708 enhancing effect Effects 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 5
- 201000004647 tinea pedis Diseases 0.000 description 5
- 241000233866 Fungi Species 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 238000004332 deodorization Methods 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 208000035240 Disease Resistance Diseases 0.000 description 3
- 208000007101 Muscle Cramp Diseases 0.000 description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 206010043268 Tension Diseases 0.000 description 3
- 108010022394 Threonine synthase Proteins 0.000 description 3
- 230000000172 allergic effect Effects 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000019522 cellular metabolic process Effects 0.000 description 3
- 102000004419 dihydrofolate reductase Human genes 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 229960000304 folic acid Drugs 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 239000011724 folic acid Substances 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 210000000653 nervous system Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 238000001467 acupuncture Methods 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241001480036 Epidermophyton floccosum Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000893976 Nannizzia gypsea Species 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000029865 regulation of blood pressure Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 201000009642 tinea barbae Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B7/00—Footwear with health or hygienic arrangements
- A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
- A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
- A43B7/1455—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form with special properties
- A43B7/146—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form with special properties provided with acupressure points or means for foot massage
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B13/00—Soles; Sole-and-heel integral units
- A43B13/02—Soles; Sole-and-heel integral units characterised by the material
- A43B13/12—Soles with several layers of different materials
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B13/00—Soles; Sole-and-heel integral units
- A43B13/14—Soles; Sole-and-heel integral units characterised by the constructive form
- A43B13/22—Soles made slip-preventing or wear-resisting, e.g. by impregnation or spreading a wear-resisting layer
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B3/00—Footwear characterised by the shape or the use
- A43B3/34—Footwear characterised by the shape or the use with electrical or electronic arrangements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
- A61H39/04—Devices for pressing such points, e.g. Shiatsu or Acupressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/06—Magnetotherapy using magnetic fields produced by permanent magnets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B33/00—Layered products characterised by particular properties or particular surface features, e.g. particular surface coatings; Layered products designed for particular purposes not covered by another single class
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
- B32B5/02—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by structural features of a fibrous or filamentary layer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
- B32B5/18—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by features of a layer of foamed material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2307/00—Properties of the layers or laminate
- B32B2307/70—Other properties
- B32B2307/724—Permeability to gases, adsorption
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rehabilitation Therapy (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Finger-Pressure Massage (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610517536.XA CN106108233B (zh) | 2016-07-04 | 2016-07-04 | 气血循环智能鞋 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610517536.XA CN106108233B (zh) | 2016-07-04 | 2016-07-04 | 气血循环智能鞋 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106108233A true CN106108233A (zh) | 2016-11-16 |
CN106108233B CN106108233B (zh) | 2017-07-04 |
Family
ID=57469137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610517536.XA Expired - Fee Related CN106108233B (zh) | 2016-07-04 | 2016-07-04 | 气血循环智能鞋 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106108233B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107455837A (zh) * | 2017-08-23 | 2017-12-12 | 广东富琳健康产业有限公司 | 一种多功能气血养生鞋 |
CN109288520A (zh) * | 2018-09-16 | 2019-02-01 | 华北理工大学 | 一种脊柱康复系统中的表面肌电检测装置 |
CN112056689A (zh) * | 2020-09-15 | 2020-12-11 | 柯信亦 | 一种中药气血循环智能鞋 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120317843A1 (en) * | 2011-06-20 | 2012-12-20 | Thomas Bove | Shoe sole system providing a negative ion environment |
CN202819781U (zh) * | 2012-08-23 | 2013-03-27 | 高华文 | 一种带有计步及定位功能的鞋 |
CN103734974A (zh) * | 2014-01-23 | 2014-04-23 | 崔学军 | 一种远红磁性保健功能鞋 |
CN204048244U (zh) * | 2014-09-16 | 2014-12-31 | 华南理工大学 | 一种基于压力传感的智能运动鞋 |
CN205030600U (zh) * | 2015-08-18 | 2016-02-17 | 苏耀勤 | 一种儿童适穿高帮鞋 |
CN105520267A (zh) * | 2016-01-20 | 2016-04-27 | 张必清 | 一种聚能磁疗保健鞋 |
-
2016
- 2016-07-04 CN CN201610517536.XA patent/CN106108233B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120317843A1 (en) * | 2011-06-20 | 2012-12-20 | Thomas Bove | Shoe sole system providing a negative ion environment |
CN202819781U (zh) * | 2012-08-23 | 2013-03-27 | 高华文 | 一种带有计步及定位功能的鞋 |
CN103734974A (zh) * | 2014-01-23 | 2014-04-23 | 崔学军 | 一种远红磁性保健功能鞋 |
CN204048244U (zh) * | 2014-09-16 | 2014-12-31 | 华南理工大学 | 一种基于压力传感的智能运动鞋 |
CN205030600U (zh) * | 2015-08-18 | 2016-02-17 | 苏耀勤 | 一种儿童适穿高帮鞋 |
CN105520267A (zh) * | 2016-01-20 | 2016-04-27 | 张必清 | 一种聚能磁疗保健鞋 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107455837A (zh) * | 2017-08-23 | 2017-12-12 | 广东富琳健康产业有限公司 | 一种多功能气血养生鞋 |
CN107455837B (zh) * | 2017-08-23 | 2018-09-11 | 广东富琳健康产业有限公司 | 一种多功能气血养生鞋 |
CN109288520A (zh) * | 2018-09-16 | 2019-02-01 | 华北理工大学 | 一种脊柱康复系统中的表面肌电检测装置 |
CN109288520B (zh) * | 2018-09-16 | 2021-06-15 | 华北理工大学 | 一种脊柱康复系统中的表面肌电检测装置 |
CN112056689A (zh) * | 2020-09-15 | 2020-12-11 | 柯信亦 | 一种中药气血循环智能鞋 |
Also Published As
Publication number | Publication date |
---|---|
CN106108233B (zh) | 2017-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106108233B (zh) | 气血循环智能鞋 | |
CN202035552U (zh) | 一种强力吸湿多功能保健鞋垫 | |
CN101999777A (zh) | 自动气循环足底减震按摩鞋垫 | |
CN204292318U (zh) | 一种适用于糖尿病足患者的鞋子 | |
CN202760319U (zh) | 一种磁疗药物鞋垫 | |
CN201995733U (zh) | 自动气循环足底减震按摩鞋垫 | |
CN210158114U (zh) | 一种新型抗菌防臭芳香保健鞋垫 | |
CN201726956U (zh) | 一种新型保健鞋垫 | |
CN210471158U (zh) | 磁疗药疗按摩健康功能鞋 | |
CN201098469Y (zh) | 纳米抗菌光磁鞋 | |
CN211558970U (zh) | 分体式多功能足部矫正鞋垫 | |
CN210184685U (zh) | 一种内分泌调节医疗鞋垫 | |
CN204708114U (zh) | 负离子保健鞋底垫 | |
CN201304068Y (zh) | 带中药囊的冠心病按摩胸罩 | |
CN204070801U (zh) | 一种保健鞋垫 | |
CN207653688U (zh) | 一种可减轻足底压力的糖尿病足保健鞋垫 | |
CN203801866U (zh) | 一种可矫正扁平足的保健鞋垫 | |
CN206499019U (zh) | 智能微循环理疗鞋垫 | |
CN210696208U (zh) | 磁疗药疗按摩健康功能鞋垫 | |
CN207370873U (zh) | 足部疼痛治疗袜套 | |
CN107549927A (zh) | 一种具有保健理疗功能的鞋垫 | |
CN204015297U (zh) | 一种具有脚底部磁疗按摩功能的鞋垫 | |
CN205359727U (zh) | 一种自动矫正脊柱的健康负跟鞋 | |
CN206165965U (zh) | 一种涌泉穴按摩鞋垫 | |
CN207370203U (zh) | 一种保健舒适鞋垫 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190717 Address after: 511400 No. 106 Fengze East Road, Nansha District, Guangzhou City, Guangdong Province (Building No. 1), X1301-A1839 Patentee after: GUANGDONG FULIN HEALTH INDUSTRY Co.,Ltd. Address before: Three Village town Guangdong city Zhuhai province Hengqin 519031 No. 22 unit 103 Patentee before: ZHUHAI FORLEN TECHNOLOGY DEVELOPMENT CO.,LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211130 Address after: 519000 room 105-68831, No.6 Baohua Road, Hengqin New District, Zhuhai City, Guangdong Province (centralized office area) Patentee after: ZHUHAI FORLEN TECHNOLOGY DEVELOPMENT CO.,LTD. Address before: 511400 No.106 Fengze East Road, Nansha District, Guangzhou City, Guangdong Province (self compiled Building 1) x1301-a1839 Patentee before: GUANGDONG FULIN HEALTH INDUSTRY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170704 |